Literature DB >> 35122113

Consequences of variability in α-synuclein fibril structure on strain biology.

Sara A M Holec1, Samantha L Liu1,2, Amanda L Woerman3.   

Abstract

Synucleinopathies are a group of clinically and neuropathologically distinct protein misfolding diseases caused by unique α-synuclein conformations, or strains. While multiple atomic resolution cryo-electron microscopy structures of α-synuclein fibrils are now deposited in Protein Data Bank, significant gaps in the biological consequences arising from each conformation have yet to be unraveled. Mutations in the α-synuclein gene (SNCA), cofactors, and the solvation environment contribute to the formation and maintenance of each disease-causing strain. This review highlights the impact of each of these factors on α-synuclein misfolding and discusses the implications of the resulting structural variability on therapeutic development.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Multiple system atrophy; Parkinson’s disease; Strains; Synucleinopathies; α-synuclein

Mesh:

Substances:

Year:  2022        PMID: 35122113     DOI: 10.1007/s00401-022-02403-w

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  107 in total

1.  The N-terminus of the intrinsically disordered protein α-synuclein triggers membrane binding and helix folding.

Authors:  Tim Bartels; Logan S Ahlstrom; Avigdor Leftin; Frits Kamp; Christian Haass; Michael F Brown; Klaus Beyer
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Drug resistance confounding prion therapeutics.

Authors:  David B Berry; Duo Lu; Michal Geva; Joel C Watts; Sumita Bhardwaj; Abby Oehler; Adam R Renslo; Stephen J DeArmond; Stanley B Prusiner; Kurt Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-15       Impact factor: 11.205

3.  Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements.

Authors:  Jane R Allison; Peter Varnai; Christopher M Dobson; Michele Vendruscolo
Journal:  J Am Chem Soc       Date:  2009-12-30       Impact factor: 15.419

4.  Deaths: Final Data for 2015.

Authors:  Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek; Sally C Curtin; Elizabeth Arias
Journal:  Natl Vital Stat Rep       Date:  2017-11

Review 5.  Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

Authors:  Sara Bandres-Ciga; Monica Diez-Fairen; Jonggeol Jeff Kim; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2020-01-25       Impact factor: 5.996

6.  Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein.

Authors:  Carlos W Bertoncini; Young-Sang Jung; Claudio O Fernandez; Wolfgang Hoyer; Christian Griesinger; Thomas M Jovin; Markus Zweckstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

7.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

8.  Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.

Authors:  Silke Appel-Cresswell; Carles Vilarino-Guell; Mary Encarnacion; Holly Sherman; Irene Yu; Brinda Shah; David Weir; Christina Thompson; Chelsea Szu-Tu; Joanne Trinh; Jan O Aasly; Alex Rajput; Ali H Rajput; A Jon Stoessl; Matthew J Farrer
Journal:  Mov Disord       Date:  2013-03-01       Impact factor: 10.338

9.  Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.

Authors:  David R Boyer; Binsen Li; Chuanqi Sun; Weijia Fan; Michael R Sawaya; Lin Jiang; David S Eisenberg
Journal:  Nat Struct Mol Biol       Date:  2019-11-06       Impact factor: 15.369

10.  Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

Authors:  Yasmine T Asi; Julie E Simpson; Paul R Heath; Stephen B Wharton; Andrew J Lees; Tamas Revesz; Henry Houlden; Janice L Holton
Journal:  Glia       Date:  2014-03-03       Impact factor: 7.452

View more
  2 in total

1.  α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders.

Authors:  Ivan Martinez-Valbuena; Emily Swinkin; Enrique Santamaria; Joaquin Fernandez-Irigoyen; Valerie Sackmann; Ain Kim; Jun Li; Paulina Gonzalez-Latapi; Greg Kuhlman; Suvorit Subhas Bhowmick; Naomi P Visanji; Anthony E Lang; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2022-06-24       Impact factor: 15.887

2.  Structures of α-synuclein filaments from human brains with Lewy pathology.

Authors:  Yang Yang; Yang Shi; Manuel Schweighauser; Xianjun Zhang; Abhay Kotecha; Alexey G Murzin; Holly J Garringer; Patrick W Cullinane; Yuko Saito; Tatiana Foroud; Thomas T Warner; Kazuko Hasegawa; Ruben Vidal; Shigeo Murayama; Tamas Revesz; Bernardino Ghetti; Masato Hasegawa; Tammaryn Lashley; Sjors H W Scheres; Michel Goedert
Journal:  Nature       Date:  2022-09-15       Impact factor: 69.504

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.